Starling Oncology, Inc. (STLNW) stock
STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN
$0.03+0.00 (+10.87%)
Close on Oct 30, 2026Market cap $665.51MP/E –Yield –
Starling Oncology total assets
Total assets on the balance sheet at the end of each period.
Starling Oncology's total assets was $178.23M at Jun 30, 2026. For fiscal 2025 it was $164.66M, down 4.7% from the year before. The highest annual figure on record is $261.67M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $164.66M | -4.7% |
| FY2024 | Dec 31, 2024 | $172.72M | -17.5% |
| FY2023 | Dec 31, 2023 | $209.24M | -20.0% |
| FY2022 | Dec 31, 2022 | $261.67M | +28.6% |
| FY2021 | Dec 31, 2021 | $203.44M | +209.7% |
| FY2020 | Dec 31, 2020 | $65.69M | +131278.0% |
| FY2019 | Dec 31, 2019 | $50.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $178.23M | +11.5% |
| Q1 FY2026 | Mar 31, 2026 | $168.23M | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $164.66M | -4.7% |
| Q3 FY2025 | Sep 30, 2025 | $163.62M | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $159.80M | -11.0% |
| Q1 FY2025 | Mar 31, 2025 | $164.00M | -19.8% |
| Q4 FY2024 | Dec 31, 2024 | $172.72M | -17.5% |
| Q3 FY2024 | Sep 30, 2024 | $179.18M | -17.9% |
| Q2 FY2024 | Jun 30, 2024 | $179.60M | -21.9% |
| Q1 FY2024 | Mar 31, 2024 | $204.53M | -12.8% |
| Q4 FY2023 | Dec 31, 2023 | $209.24M | -20.0% |
| Q3 FY2023 | Sep 30, 2023 | $218.35M | -23.1% |
| Q2 FY2023 | Jun 30, 2023 | $229.96M | +21.2% |
| Q1 FY2023 | Mar 31, 2023 | $234.63M | +13.6% |
| Q4 FY2022 | Dec 31, 2022 | $261.67M | +28.6% |
| Q3 FY2022 | Sep 30, 2022 | $283.80M | +23.2% |
| Q2 FY2022 | Jun 30, 2022 | $189.74M | -17.8% |
| Q1 FY2022 | Mar 31, 2022 | $206.51M | -10.6% |
| Q4 FY2021 | Dec 31, 2021 | $203.44M | +209.7% |
| Q3 FY2021 | Sep 30, 2021 | $230.30M | -0.5% |
| Q2 FY2021 | Jun 30, 2021 | $230.75M | -0.3% |
| Q1 FY2021 | Mar 31, 2021 | $231.04M | -0.3% |
| Q4 FY2020 | Dec 31, 2020 | $65.69M | +131278.0% |
| Q3 FY2020 | Sep 30, 2020 | $231.40M | – |
| Q2 FY2020 | Jun 30, 2020 | $231.47M | – |
| Q1 FY2020 | Mar 31, 2020 | $231.84M | – |
| Q4 FY2019 | Dec 31, 2019 | $50.00K | – |